메뉴 건너뛰기




Volumn 33, Issue 6, 2001, Pages 1527-1532

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PLACEBO; VIRUS DNA;

EID: 0034993211     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.25084     Document Type: Article
Times cited : (621)

References (19)
  • 1
    • 0029893071 scopus 로고    scopus 로고
    • Epidemiology of hepatitis B infection in the Western Pacific and South East Asia
    • (1996) Gut , vol.38 , pp. S18-S23
    • Gust, I.D.1
  • 3
    • 0032783736 scopus 로고    scopus 로고
    • Lamivudine. A review of its therapeutic potential in chronic hepatitis B
    • (1999) Drugs , vol.58 , pp. 101-141
    • Jarvis, B.1    Faulds, D.2
  • 9
    • 0032869876 scopus 로고    scopus 로고
    • Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B
    • (1999) Hepatology , vol.30 , pp. 770-774
    • Chien, R.N.1    Liaw, Y.F.2    Atkins, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.